Amgen Inc (NASDAQ:AMGN)

222.96
Delayed Data
As of Feb 19
 +1.27 / +0.57%
Today’s Change
166.30
Today|||52-Week Range
244.99
-7.51%
Year-to-Date
3 Biotech Stocks That Made Early Shareholders Millionaires
Feb 13 / MotleyFool.com - Paid Partner Content
Is Amgen a Stock to Buy?
Feb 08 / MotleyFool.com - Paid Partner Content
Bristol-Myers Squibb Stock Is Too Cheap to Ignore
Feb 10 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close221.69
Today’s open222.94
Day’s range222.05 - 224.05
Volume1,322,884
Average volume (3 months)2,241,702
Market cap$131.7B
Data as of 4:00pm ET, 02/19/2020

Growth & Valuation

Earnings growth (last year)+2.07%
Earnings growth (this year)+6.57%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)-2.13%
P/E ratio17.3
Price/Sales6.31
Price/Book13.65

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.34+0.51%
BIIBBiogen+3.94+1.17%
ILMNIllumina Inc+3.28+1.09%
BMRNBiomarin Pharmaceuti...+0.93+1.05%
Data as of 4:00pm ET, 02/19/2020

Financials

Next reporting dateApril 28, 2020
EPS forecast (this quarter)$3.78
Annual revenue (last year)$23.3B
Annual profit (last year)$7.8B
Net profit margin33.71%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Thousand Oaks, California

Forecasts